MeiraGTx Holdings plc revenue breakdown overview

MeiraGTx Holdings plc revenue for the last year amounted to 33.28 M USD, the most of which — 33.28 M USD — came from its highest performing source at the moment, Retinal Drugs and Gene Therapies, the year earlier bringing 14.02 M USD. The greatest contribution to the revenue figure was made by United Kingdom — last year it brought MeiraGTx Holdings plc 33.28 M USD, and the year before that — 14.02 M USD.